BioSpace News Archive

Therapix Biosciences Ltd. (“Therapix” or the “Company”) (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announces today that the Company has delivered notice of termination to FSD Pharma Inc. (“FSD”) under the previously announced binding letter of intent dated October 22, 2018 (the “LOI”) for the acquisition of the Company by FSD (the “Transaction”).

OncoSec Medical Inc. (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, announced today that Joon Kim, J.D., a partner at Lee & Ko, has been appointed to OncoSec’s Board of Directors.

Harvest Health & Recreation, Inc. (Harvest), a vertically integrated public cannabis company with one of the largest footprints in the United States and now listed publicly on the CSE in Canada (CSE: HARV), was awarded the highest score of all applicants and received one of only two licenses to operate a dispensary in Santa Monica, California.

Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, announced today that the company applauds the United States Congress for the passage of The Agricultural Improvement Act of 2018, also known as the 2018 Farm Bill, that includes Senate Majority Leader Mitch McConnell’s Hemp Farming Act of 2018.

Zymergen, the world’s first molecular manufacturing technology company, announced today the appointment of Jens Peter Clausen as Senior Vice President, Global Manufacturing.

The Walgreens Flu Index™ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranks those states and markets experiencing the highest incidences of influenza across the country.

Officials from Onslow Memorial Hospital and UNC Health Care announced that they are finalizing a management agreement that will begin in January.

The latest version of the innovative radiation therapy treatment planning system (TPS) RayStation has been released*

Almac Clinical Services, part of the global contract pharmaceutical development and manufacturing organisation the Almac Group, is pleased to invite participants from the pharmaceutical and biopharma industries to join its San Diego lunch and learn to discuss cold chain management in clinical trials.

Boston Scientific Corporation (NYSE: BSX) will participate in the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 in San Francisco, California.